Schmidtke G, Kraft R, Kostka S, Henklein P, Frömmel C, Löwe J, Huber R, Kloetzel P M, Schmidt M
Institut für Biochemie, Charité, Humboldt Universität zu Berlin, Germany.
EMBO J. 1996 Dec 16;15(24):6887-98.
Maturation of eukaryotic 20S proteasomes involves the processing of beta-subunits by limited proteolysis. To study the processing mechanism we analysed different point mutations of the beta-subunit LMP2 in transfected human T2 cells. Here we show that the presence of the intact Gly-1Thr1 consensus motif and Lys33 are essential for correct processing. Mutation of Thr1, the active site residue in mature subunits, or of Lys33, results in complete inhibition of processing at the consensus site. In addition, proprotein processing in vitro of wild-type LMP2, incorporated in immature 16S precursor complexes, can be blocked by a proteasome-specific inhibitor. While the processing of inhibitor-treated wild-type proprotein was completely prevented, the site-directed mutagenesis of LMP2 results in processing intermediates carrying an extension of 8-10 residues preceding Thr1, suggesting an additional cleavage event within the prosequence. Furthermore, exchange of mammalian prosequences interferes with processing efficiency and suggests subunit specificity. Based on our data we propose a model for self-activation of proteasomal beta-subunits in which residue Thr1 serves as nucleophile and Lys33 as proton donor/acceptor. We provide evidence that subunit processing of mammalian beta-subunits proceeds via a novel ordered two-step mechanism involving autocatalysis.
真核生物20S蛋白酶体的成熟涉及通过有限蛋白水解对β亚基进行加工。为了研究加工机制,我们分析了转染的人T2细胞中β亚基LMP2的不同点突变。在此我们表明,完整的Gly-1Thr1共有基序和Lys33的存在对于正确加工至关重要。成熟亚基中的活性位点残基Thr1或Lys33的突变会导致共有位点处的加工完全受到抑制。此外,掺入未成熟16S前体复合物中的野生型LMP2在体外的前体蛋白加工可被蛋白酶体特异性抑制剂阻断。虽然抑制剂处理的野生型前体蛋白的加工被完全阻止,但LMP2的定点诱变导致加工中间体在Thr1之前带有8-10个残基的延伸,这表明在前序列内存在额外的切割事件。此外,哺乳动物前序列的交换会干扰加工效率并表明亚基特异性。基于我们的数据,我们提出了一种蛋白酶体β亚基自我激活的模型,其中残基Thr1作为亲核试剂,Lys33作为质子供体/受体。我们提供的证据表明,哺乳动物β亚基的亚基加工通过一种涉及自催化的新型有序两步机制进行。